Long-term evaluation of terbinafine 250 and 500 mg daily in a 16-week oral treatment for toenail onychomycosis.
De Cuyper
C
C
D000935:Antifungal Agents / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D005533:Foot Dermatoses / Q000188:drug therapy; D006801:Humans; D009281:Naphthalenes / Q000008:administration & dosage*; D014009:Onychomycosis / Q000188:drug therapy*; D000077291:Terbinafine
D000935:Antifungal Agents; D009281:Naphthalenes; D000077291:Terbinafine